<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="4.2.0">Jekyll</generator><link href="/feed.xml" rel="self" type="application/atom+xml" /><link href="/" rel="alternate" type="text/html" /><updated>2021-07-22T12:31:07+02:00</updated><id>/feed.xml</id><entry><title type="html">Weeknotes</title><link href="/2021/07/19/weeknotes_8.html" rel="alternate" type="text/html" title="Weeknotes" /><published>2021-07-19T00:00:00+02:00</published><updated>2021-07-19T00:00:00+02:00</updated><id>/2021/07/19/weeknotes_8</id><content type="html" xml:base="/2021/07/19/weeknotes_8.html">&lt;h1 id=&quot;weeknotes&quot;&gt;Weeknotes&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;19 July 2021&lt;/p&gt;

&lt;h1 id=&quot;work&quot;&gt;Work&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Methods for comparing odds ratios and CI in subset analysis.&lt;/li&gt;
  &lt;li&gt;Writing paper on &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&amp;amp;VirusLineage_ss=Human%20orthopneumovirus,%20taxid:11250&quot;&gt;viral association genetics&lt;/a&gt;.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;personal&quot;&gt;Personal&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Reviewing Altman &amp;amp; Bland yet another paper from &lt;a href=&quot;https://www-users.york.ac.uk/~mb55/pubs/pbstnote.htm&quot;&gt;Statistics Notes in the British Medical Journal&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;reading&quot;&gt;Reading&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Fabiani et Bercovici - &lt;a href=&quot;https://www.bedetheque.com/BD-Incroyable-Histoire-de-la-medecine-L-Incroyable-Histoire-de-la-medecine-354061.html&quot;&gt;L’incroyable Histoire de la médecine&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://www.lesswrong.com/posts/vwqLfDfsHmiavFAGP/the-library-of-scott-alexandria&quot;&gt;The Library of Scott Alexandria&lt;/a&gt;
&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E05](https://www.youtube.com/watch?v=3v6k53bHX4A&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=5 --&gt;
&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E06](https://www.youtube.com/watch?v=pga0Oi1cZvo&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=6 --&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;other-media&quot;&gt;Other media&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Dan Carlin’s Hardcore History - &lt;a href=&quot;https://www.dancarlin.com/product/hardcore-history-66-supernova-in-the-east-v/&quot;&gt;Supernova in the East V&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;</content><author><name></name></author><category term="weeknotes" /><summary type="html">Weeknotes</summary></entry><entry><title type="html">Weeknotes</title><link href="/2021/07/12/weeknotes_7.html" rel="alternate" type="text/html" title="Weeknotes" /><published>2021-07-12T00:00:00+02:00</published><updated>2021-07-12T00:00:00+02:00</updated><id>/2021/07/12/weeknotes_7</id><content type="html" xml:base="/2021/07/12/weeknotes_7.html">&lt;h1 id=&quot;weeknotes&quot;&gt;Weeknotes&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;12 July 2021&lt;/p&gt;

&lt;h1 id=&quot;work&quot;&gt;Work&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Writing paper on &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&amp;amp;VirusLineage_ss=Human%20orthopneumovirus,%20taxid:11250&quot;&gt;viral association genetics&lt;/a&gt;.&lt;/li&gt;
  &lt;li&gt;Methods for pruning SNPs by correlation in cohort. &lt;a href=&quot;https://privefl.github.io/bigsnpr/articles/pruning-vs-clumping.html&quot;&gt;e.g.&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Human whole genome analysis.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;personal&quot;&gt;Personal&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Reviewing Altman &amp;amp; Bland another paper from &lt;a href=&quot;https://www-users.york.ac.uk/~mb55/pubs/pbstnote.htm&quot;&gt;Statistics Notes in the British Medical Journal&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Designing a poster and illustrations of viral structure, proteins, and genetics.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;reading&quot;&gt;Reading&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Robert Bringhurst - &lt;a href=&quot;https://www.bookdepository.com/search?searchTerm=The+Elements+of+Typographic+Style&amp;amp;search=Find+book&quot;&gt;The Elements of Typographic Style&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://www.lesswrong.com/posts/vwqLfDfsHmiavFAGP/the-library-of-scott-alexandria&quot;&gt;The Library of Scott Alexandria&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E05](https://www.youtube.com/watch?v=3v6k53bHX4A&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=5 --&gt;
&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E06](https://www.youtube.com/watch?v=pga0Oi1cZvo&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=6 --&gt;

&lt;h1 id=&quot;other-media&quot;&gt;Other media&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Dan Carlin’s Hardcore History - &lt;a href=&quot;https://www.dancarlin.com/product/hardcore-history-65-supernova-in-the-east-iv/&quot;&gt;Supernova in the East IV&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;</content><author><name></name></author><category term="weeknotes" /><summary type="html">Weeknotes</summary></entry><entry><title type="html">Credited for a newly added immune gene in IUIS</title><link href="/2021/07/08/iuis.html" rel="alternate" type="text/html" title="Credited for a newly added immune gene in IUIS" /><published>2021-07-08T00:00:00+02:00</published><updated>2021-07-08T00:00:00+02:00</updated><id>/2021/07/08/iuis</id><content type="html" xml:base="/2021/07/08/iuis.html">&lt;h1 id=&quot;credited-for-a-newly-added-immune-gene-in-iuis&quot;&gt;Credited for a newly added immune gene in IUIS&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;08 Feb 2021&lt;/p&gt;

&lt;p&gt;Our recent paper 
&lt;em&gt;Germline TET2 loss of function causes childhood immunodeficiency and lymphoma&lt;/em&gt;
&lt;a class=&quot;citation&quot; href=&quot;#stremenova2020germline&quot;&gt;(Stremenova Spegarova et al., 2020)&lt;/a&gt; has been 
credited for a newly added immune gene in &lt;em&gt;Novel inborn errors of immunity: an Interim Update by the IUIS Committee&lt;/em&gt;
&lt;a href=&quot;https://doi.org/10.1007/s10875-021-00980-1&quot;&gt;full link&lt;/a&gt;,
&lt;a href=&quot;https://link.springer.com/content/pdf/10.1007/s10875-021-00980-1.pdf&quot;&gt;pdf&lt;/a&gt;,
as &lt;a href=&quot;https://link.springer.com/article/10.1007/s10875-021-00980-1/tables/1&quot;&gt;TET2 in table 1&lt;/a&gt;
&lt;a class=&quot;citation&quot; href=&quot;#tangye2021ever&quot;&gt;(Tangye et al., 2021)&lt;/a&gt;.
It has been included for the gene list of &lt;em&gt;Autoinflammatory diseases&lt;/em&gt; based on our work in 3 patients, 2 families with autosomal recessive loss-of-function.
Since I began research on the genomics of immunology, the IUIS list of genes has been an extremely important reference for my work to which I am now thrilled to &lt;em&gt;give back&lt;/em&gt;.&lt;/p&gt;

&lt;p&gt;International Union of Immunological Societies (IUIS) &lt;a href=&quot;https://iuis.org&quot;&gt;IUIS.org&lt;/a&gt;;&lt;/p&gt;
&lt;blockquote&gt;
  &lt;p&gt;The International Union of Immunological Societies (IUIS) is an umbrella organization for many of the regional and national societies of immunology throughout the world. As articulated in its Constitution, the objectives of IUIS are:&lt;/p&gt;
  &lt;ul&gt;
    &lt;li&gt;to organize international co-operation in immunology and to promote communication between the various branches of immunology and allied subjects&lt;/li&gt;
    &lt;li&gt;to encourage within each scientifically independent territory co-operation between the Societies that represent the interests of immunology&lt;/li&gt;
    &lt;li&gt;to contribute to the advancement of immunology in all its aspects.&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;p&gt;From &lt;em&gt;Novel inborn errors of immunity: an Interim Update by the IUIS Committee&lt;/em&gt;,&lt;/p&gt;
&lt;blockquote&gt;
  &lt;p&gt;Inborn errors of immunity (IEI) are generally considered to result from monogenic germline defects that manifest as increased susceptibility to severe and/or recurrent infectious diseases, autoimmune or autoinflammatory conditions, atopic manifestations, and hematopoietic or solid tissue malignancies [&lt;a href=&quot;https://doi.org/10.1126/sciimmunol.abb1662&quot;&gt;1&lt;/a&gt;]. 
Over the past decade, the discovery of new IEIs has been occurring at an impressive rate. 
Indeed, the 2011 biennial update published by the IUIS Committee update listed 191 IEIs; this number increased to 430 in the 2019 update
[&lt;a href=&quot;https://doi.org/10.1007/s10875-020-00758-x&quot;&gt;2&lt;/a&gt;],
[&lt;a href=&quot;https://doi.org/10.1007/s10875-019-00737-x&quot;&gt;3&lt;/a&gt;].
This near-exponential increase in gene discovery is being driven by the accessibility and affordability of next-generation sequencing, and the efficient application of these technologies to elucidate the molecular etiology of unsolved cases of IEIs that are likely to result from single-gene defects
&lt;a href=&quot;https://doi.org/10.1016/j.jaci.2016.08.003&quot;&gt;4&lt;/a&gt;.&lt;/p&gt;

  &lt;p&gt;Over the last 12 months, we have witnessed the ongoing rapid identification, and occasionally detailed molecular, biochemical, and cellular characterization, of genetic variants that cause, or are at least associated with, human diseases impacting host defense or immune regulation.
Here, we will summarize reports on variants detected in 26 genes which we consider represent novel IEI 
(&lt;a href=&quot;https://link.springer.com/article/10.1007/s10875-021-00980-1/tables/1&quot;&gt;Table 1&lt;/a&gt;).
Many additional genetic variants have been reported recently. 
However, those listed here have been adjudicated by the IUIS Committee to meet the strict criteria to be considered disease-causing
&lt;a href=&quot;https://doi.org/10.1084/jem.20140520&quot;&gt;57&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;Our paper took several years to complete, 
although the genomic analysis worked incredibly well in this case - 
a patient presented as described in &lt;strong&gt;figure 1&lt;/strong&gt; (Fig. S3 in publication);
after running the routine pipeline that we had made, the result was immediately the top candidate, number one, as cause of disease in a single patient, lymphoma with immunodeficiency and autoinflammtory disease
&lt;a class=&quot;citation&quot; href=&quot;#stremenova2020germline&quot;&gt;(Stremenova Spegarova et al., 2020)&lt;/a&gt;.
We then found that our collaborator had a second family with a LoF in the same gene causing the same severe immunological features.
By combining the families for further genomic and functional analysis work over several years we finally produced a robust explanation for the disease and strong evidence of the immunological features.
The summarised information can be read in 
&lt;a href=&quot;https://link.springer.com/article/10.1007/s10875-021-00980-1/tables/1&quot;&gt;Table 1 Newly validated inborn errors of immunity&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Figure 1.&lt;/strong&gt; Patient histories as shown in the published 
&lt;em&gt;Supplemental Figure S3: Clinical timelines&lt;/em&gt;
(this version with legend is an extract my PhD thesis).
&lt;a href=&quot;/images/posts/clinical_history_summary.pdf&quot;&gt;(pdf version)&lt;/a&gt;.&lt;/p&gt;

&lt;object data=&quot;/images/posts/clinical_history_summary.pdf&quot; type=&quot;application/pdf&quot; width=&quot;100%&quot; style=&quot;height:700px;&quot;&gt;

The gene of interest, _TET2_ is intriguing since it is the monogenic cause of disease but has a widespread mechanism of action throughout the genome by epigenetic effects.
From one of my unpublished documents, in reference to different types of epigenetic systems;
&amp;gt; The effect of mutations which disrupt any of these systems have been described as damaging toward (i) epigenetic modifiers, (ii) epigenetic mediators, and (iii) epigenetic modulators [[15](https://pubmed.ncbi.nlm.nih.gov/26972587/)]. Epigenetic modifiers are genes whose products have direct involvement; protein coding genes that control DNA methylation, post-translational modification, or higher-order chromatin structure (e.g. TET2, IDH, ARID). Mutation in these genes can have a cascade effect since they control the regulation of many downstream genes. The downstream genes which are targeted by the modifiers are epigenetic mediators.
&amp;gt; Damaging mutations in mediators might only be linked with epigenetics when they occur in, for example, tumour suppressor genes resulting in the same disease as mutation in one of the upstream epigenetic modifiers. Epigenetic modulators are upstream of modifiers and have the potential to induce or suppress differentiation-specific epigenetic states. Pro-inflammatory NF-κB signalling has been reported as an example of a modulator that links the environment and epigenome [[15](https://pubmed.ncbi.nlm.nih.gov/26972587/)]. Excessive signalling in this pathway can trigger an epigenetically-dependant interleukin-6 positive feed-back loop.

&lt;div class=&quot;table-wrapper&quot;&gt;

    &lt;table&gt;
      &lt;thead&gt;
        &lt;tr&gt;
          &lt;th style=&quot;text-align: center&quot;&gt;Epigenetic modulators&lt;/th&gt;
          &lt;th style=&quot;text-align: center&quot;&gt;Epigenetic modifiers&lt;/th&gt;
          &lt;th style=&quot;text-align: center&quot;&gt;Epigenetic mediators&lt;/th&gt;
        &lt;/tr&gt;
      &lt;/thead&gt;
      &lt;tbody&gt;
        &lt;tr&gt;
          &lt;td style=&quot;text-align: center&quot;&gt;Secondary effect on multiple pathways (NF-kB, IL-6)&lt;/td&gt;
          &lt;td style=&quot;text-align: center&quot;&gt;Primary effect on multiple genes (TET2, IDH1)&lt;/td&gt;
          &lt;td style=&quot;text-align: center&quot;&gt;Primary effect on single genes (IGF-2, OCT4, WNT)&lt;/td&gt;
        &lt;/tr&gt;
      &lt;/tbody&gt;
    &lt;/table&gt;

  &lt;/div&gt;

When a protein has widespread control for many other genes, a LoF variant is often embryonic lethal and would never result in a relatively narrow phenotype. 
For TET2 LoF, we found that completely disrupting the genome-wide methylation process causes a pronounced immunological phenotype.
Unfortunately, the disease can be very difficult to correct without successful haematopoietic stem cell transplantation.
In such cases, a great deal of biological understanding is gained that may otherwise have taken very long to elucidate. 

Loss of TET2 in humans has severe consequences including haematological malignancy.
Yet, it has also been shown that TET2 knock-out can improve anti-tumour therapy for the same reasons;
Fraietta et al. showed that while developing therapeutic CD19-targeted T cells (CAR-T anti-tumour therapy), the integration of the CD19-CAR sequence happened to interrupt the TET2 coding sequence by chance
&lt;a class=&quot;citation&quot; href=&quot;#fraietta2018disruption&quot;&gt;(Fraietta et al., 2018)&lt;/a&gt;.
This fortuitous integration event had a combined effect; disrupting TET2 promoted the therapeutic efficacy of CD19-targeted T cells in the patient. 
Inhibiting TET2 normally would not be considered ameliorative in cancer immunology. 
However, in this case the pathogenic effect of TET2 deficiency allowed for more successful CAR-T cell therapy. 
It is likely that this type of combined genetic alteration will improve CART function. This anecdotal example demonstrates the lymphoproliferative effect of TET2 deficiency.

## References 

&lt;ol class=&quot;bibliography&quot;&gt;&lt;li&gt;&lt;span id=&quot;stremenova2020germline&quot;&gt;Stremenova Spegarova, J., Lawless, D., Mohamad, S. M. B., Engelhardt, K. R., Doody, G., Shrimpton, J., Rensing-Ehl, A., Ehl, S., Rieux-Laucat, F., Cargo, C., &amp;amp; others. (2020). Germline TET2 loss of function causes childhood immunodeficiency and lymphoma. &lt;i&gt;Blood&lt;/i&gt;, &lt;i&gt;136&lt;/i&gt;(9), 1055–1066.&lt;/span&gt;&lt;/li&gt;
&lt;li&gt;&lt;span id=&quot;tangye2021ever&quot;&gt;Tangye, S. G., Al-Herz, W., Bousfiha, A., Cunningham-Rundles, C., Franco, J. L., Holland, S. M., Klein, C., Morio, T., Oksenhendler, E., Picard, C., &amp;amp; others. (2021). The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS committee. &lt;i&gt;Journal of Clinical Immunology&lt;/i&gt;, &lt;i&gt;41&lt;/i&gt;(3), 666–679.&lt;/span&gt;&lt;/li&gt;
&lt;li&gt;&lt;span id=&quot;fraietta2018disruption&quot;&gt;Fraietta, J. A., Nobles, C. L., Sammons, M. A., Lundh, S., Carty, S. A., Reich, T. J., Cogdill, A. P., Morrissette, J. J. D., DeNizio, J. E., Reddy, S., &amp;amp; others. (2018). Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. &lt;i&gt;Nature&lt;/i&gt;, &lt;i&gt;558&lt;/i&gt;(7709), 307.&lt;/span&gt;&lt;/li&gt;&lt;/ol&gt;
&lt;/object&gt;</content><author><name></name></author><category term="statistics" /><summary type="html">Credited for a newly added immune gene in IUIS</summary></entry><entry><title type="html">Multiple transcript variant</title><link href="/2021/07/07/Multiple_transcript_variant.html" rel="alternate" type="text/html" title="Multiple transcript variant" /><published>2021-07-07T00:00:00+02:00</published><updated>2021-07-07T00:00:00+02:00</updated><id>/2021/07/07/Multiple_transcript_variant</id><content type="html" xml:base="/2021/07/07/Multiple_transcript_variant.html">&lt;h1 id=&quot;multiple-transcript-variant&quot;&gt;Multiple transcript variant&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;07 July 2021&lt;/p&gt;

&lt;h2 id=&quot;introduction&quot;&gt;Introduction&lt;/h2&gt;
&lt;p&gt;A colleague asked me about why there are multiple mRNA transcripts with different variant positions from a single variant in human genomic DNA.
Here is a short summary to answer that question (forgiving over-simiplifications).
First, a quick recap of how DNA is used to protuce proteins.
Then an example of a gene where the mRNA could be spliced more than one way by the splisosome complex.&lt;/p&gt;

&lt;h2 id=&quot;dna-to-protein&quot;&gt;DNA to protein&lt;/h2&gt;
&lt;ol&gt;
  &lt;li&gt;Genomic DNA (only one version per cell/individual).&lt;/li&gt;
  &lt;li&gt;Transcription to pre-mRNA (one exact copy of DNA as mRNA).&lt;/li&gt;
  &lt;li&gt;Splicing pre-mRNA to mRNA transcript (introns removed by splisosome). One version or several slightly different versions.&lt;/li&gt;
  &lt;li&gt;Spliced mRNA (messenger mRNA) translated into amino acid peptide chain.&lt;/li&gt;
  &lt;li&gt;Peptide chain folds into protein.&lt;/li&gt;
&lt;/ol&gt;

&lt;p&gt;Genomic DNA is transcripted over and over, in every cell (ignoring tissue-speicif expression, dynamics, etc.).
When the pre-mRNA is spliced, there may be multiple versions produced.
It all depends on how the splicing complex recognizes the intron/exon sequences. 
This also explains why &lt;em&gt;splice mutations&lt;/em&gt; occur in 4-5 the nucleotides around the junction between exon and intron. 
The is the part of the sequence that is recognised by the splisosome.&lt;/p&gt;

&lt;p&gt;&lt;a href=&quot;https://www.researchgate.net/profile/Alen-Faiz/publication/224006658/figure/fig3/AS:203040918380546@1425420135624/Transcripts-from-a-single-gene-can-undergo-different-splicing-events-When-mRNA-is_W840.jpg&quot;&gt;image0&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;&lt;a href=&quot;http://fig.cox.miami.edu/~cmallery/255/255hist/mcb4.1.dogma.jpg&quot;&gt;image1&lt;/a&gt;&lt;/p&gt;

&lt;h2 id=&quot;transcript-example&quot;&gt;Transcript example&lt;/h2&gt;
&lt;p&gt;Transcript [1]
&lt;a href=&quot;https://www.ensembl.org/Homo_sapiens/Transcript/Exons?db=core;g=ENSG00000104343;r=8:73780097-73878910;t=ENST00000650817&quot;&gt;link to ensemble/UBE2W-207&lt;/a&gt;&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Transcript UBE2W-207 ENST00000602593.6 8379bp 151aa.&lt;/li&gt;
  &lt;li&gt;Exon 1 is 103 nucleotides.&lt;/li&gt;
  &lt;li&gt;position start 73,878,910	end 73,878,808.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;Transcript [2]
&lt;a href=&quot;https://www.ensembl.org/Homo_sapiens/Transcript/Exons?db=core;g=ENSG00000104343;r=8:73780097-73878910;t=ENST00000602593&quot;&gt;link to ensemble/UBE2W-208&lt;/a&gt;&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Transcript UBE2W-208 ENST00000650817.1 8459bp	191aa.&lt;/li&gt;
  &lt;li&gt;Exon 1 is 55 nucleotides.&lt;/li&gt;
  &lt;li&gt;position start 73,878,862	end 73,878,808.&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;mutation-example&quot;&gt;Mutation example&lt;/h2&gt;
&lt;p&gt;A DNA mutation at position g.73,878,863 A&amp;gt;T&lt;/p&gt;

&lt;p&gt;This mutation will only affect transcript [2] at
cDNA (mRNA) position c.2A&amp;gt;T
and protein position p.Met1Leu.&lt;/p&gt;

&lt;p&gt;Transcript [1] is not affected because the coding sequence begins later in the DNA sequence.&lt;/p&gt;

&lt;h2 id=&quot;cdna-note&quot;&gt;cDNA note&lt;/h2&gt;
&lt;p&gt;The cDNA position notation is used for simplicity. 
We assume the parts of genomic DNA that will remain after splicing (introns and upstream/downstream sequences removed), and call this the coding DNA (cDNA).
We can physically create cDNA when we collect mRNA from a cell and do reverse Transcription PCR (RT-PCR) to make a DNA copy.&lt;/p&gt;

&lt;p&gt;&lt;a href=&quot;https://www.mun.ca/biology/desmid/brian/BIOL2060/BIOL2060-21/21_22.jpg&quot;&gt;image2&lt;/a&gt;
&lt;a href=&quot;https://i.servimg.com/u/f21/17/30/76/23/splice10.png&quot;&gt;image3&lt;/a&gt;&lt;/p&gt;</content><author><name></name></author><category term="statistics" /><summary type="html">Multiple transcript variant</summary></entry><entry><title type="html">Weeknotes</title><link href="/2021/07/05/weeknotes_6.html" rel="alternate" type="text/html" title="Weeknotes" /><published>2021-07-05T00:00:00+02:00</published><updated>2021-07-05T00:00:00+02:00</updated><id>/2021/07/05/weeknotes_6</id><content type="html" xml:base="/2021/07/05/weeknotes_6.html">&lt;h1 id=&quot;weeknotes&quot;&gt;Weeknotes&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;05 July 2021&lt;/p&gt;

&lt;h1 id=&quot;work&quot;&gt;Work&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Writing paper on &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&amp;amp;VirusLineage_ss=Human%20orthopneumovirus,%20taxid:11250&quot;&gt;viral association genetics&lt;/a&gt;.&lt;/li&gt;
  &lt;li&gt;Functional interpretation of mutation analysis for RSV F and G proteins.&lt;/li&gt;
  &lt;li&gt;Human whole genome analysis.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;personal&quot;&gt;Personal&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Learning how to annotate protein structures.&lt;/li&gt;
  &lt;li&gt;Reviewing Altman &amp;amp; Bland papers from &lt;a href=&quot;https://www-users.york.ac.uk/~mb55/pubs/pbstnote.htm&quot;&gt;Statistics Notes in the British Medical Journal&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;reading&quot;&gt;Reading&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;&lt;a href=&quot;https://www.amazon.com/Genetics-Analysis-Quantitative-Traits-Michael/dp/0878934812&quot;&gt;Genetics and Analysis of Quantitative Traits&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Robert Bringhurst - &lt;a href=&quot;https://www.bookdepository.com/search?searchTerm=The+Elements+of+Typographic+Style&amp;amp;search=Find+book&quot;&gt;The Elements of Typographic Style&lt;/a&gt; 
&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E05](https://www.youtube.com/watch?v=3v6k53bHX4A&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=5 --&gt;
&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E06](https://www.youtube.com/watch?v=pga0Oi1cZvo&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=6 --&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;other-media&quot;&gt;Other media&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Dan Carlin’s Hardcore History - &lt;a href=&quot;https://www.dancarlin.com/product/hardcore-history-64-supernova-in-the-east-iii/&quot;&gt;Supernova in the East III&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;</content><author><name></name></author><category term="weeknotes" /><summary type="html">Weeknotes</summary></entry><entry><title type="html">Weeknotes</title><link href="/2021/06/28/weeknotes_5.html" rel="alternate" type="text/html" title="Weeknotes" /><published>2021-06-28T00:00:00+02:00</published><updated>2021-06-28T00:00:00+02:00</updated><id>/2021/06/28/weeknotes_5</id><content type="html" xml:base="/2021/06/28/weeknotes_5.html">&lt;h1 id=&quot;weeknotes&quot;&gt;Weeknotes&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;28 June 2021&lt;/p&gt;

&lt;h1 id=&quot;work&quot;&gt;Work&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Writing paper on &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&amp;amp;VirusLineage_ss=Human%20orthopneumovirus,%20taxid:11250&quot;&gt;viral association genetics&lt;/a&gt;.&lt;/li&gt;
  &lt;li&gt;Protein structure visualisation and mutation analysis for RSV F and G proteins.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;personal&quot;&gt;Personal&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Learning how to embed a protein structure viewer in websites.&lt;/li&gt;
  &lt;li&gt;Reviewing Altman &amp;amp; Bland &lt;a href=&quot;https://www-users.york.ac.uk/~mb55/pubs/pbstnote.htm&quot;&gt;Statistics Notes in the British Medical Journal&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;reading&quot;&gt;Reading&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;&lt;a href=&quot;http://fuel-design.com/publishing/soviet-cities/&quot;&gt;Soviet Cities, Arseniy Kotov&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://www.amazon.com/Genetics-Analysis-Quantitative-Traits-Michael/dp/0878934812&quot;&gt;Genetics and Analysis of Quantitative Traits&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Chapter 3 in reading &lt;a href=&quot;https://en.wikisource.org/wiki/Reading_Marx%27s_Capital_Vol_I_with_David_Harvey/Class_3&quot;&gt;Capital with David Harvey&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E05](https://www.youtube.com/watch?v=3v6k53bHX4A&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=5 --&gt;
&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E06](https://www.youtube.com/watch?v=pga0Oi1cZvo&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=6 --&gt;

&lt;h1 id=&quot;other-media&quot;&gt;Other media&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Adam Curtis documentary: &lt;a href=&quot;https://www.youtube.com/watch?v=UglBcbz5pzQ&amp;amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;amp;index=4&quot;&gt;Cant Get You Out of My Head E04&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Dan Carlin’s Hardcore History - &lt;a href=&quot;https://www.dancarlin.com/product/hardcore-history-63-supernova-in-the-east-ii/&quot;&gt;Supernova in the East II&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Komeda Quintet - &lt;a href=&quot;https://youtube.com/playlist?list=PLB5sZsze0CR9FRtpZ3OiSh-8pVc9Q0X5r&quot;&gt;Astigmatic (1966): Avant-garde Jazz&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;</content><author><name></name></author><category term="weeknotes" /><summary type="html">Weeknotes</summary></entry><entry><title type="html">Weeknotes</title><link href="/2021/06/21/weeknotes_4.html" rel="alternate" type="text/html" title="Weeknotes" /><published>2021-06-21T00:00:00+02:00</published><updated>2021-06-21T00:00:00+02:00</updated><id>/2021/06/21/weeknotes_4</id><content type="html" xml:base="/2021/06/21/weeknotes_4.html">&lt;h1 id=&quot;weeknotes&quot;&gt;Weeknotes&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;21 June 2021&lt;/p&gt;

&lt;h1 id=&quot;work&quot;&gt;Work&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Writing up paper on protein network analysis.&lt;/li&gt;
  &lt;li&gt;Writing paper on &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&amp;amp;VirusLineage_ss=Human%20orthopneumovirus,%20taxid:11250&quot;&gt;viral association genetics&lt;/a&gt;.&lt;/li&gt;
  &lt;li&gt;Discussions with students about joining for projects.&lt;/li&gt;
  &lt;li&gt;MSc student completes project and report.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;personal&quot;&gt;Personal&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Learning how to embed a FATSA multiple sequence alignment viewer in websites.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;reading&quot;&gt;Reading&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;&lt;a href=&quot;http://fuel-design.com/publishing/soviet-cities/&quot;&gt;Soviet Cities, Arseniy Kotov&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://www.amazon.com/Genetics-Analysis-Quantitative-Traits-Michael/dp/0878934812&quot;&gt;Genetics and Analysis of Quantitative Traits&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E04](https://www.youtube.com/watch?v=UglBcbz5pzQ&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=4 --&gt;
&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E05](https://www.youtube.com/watch?v=3v6k53bHX4A&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=5 --&gt;
&lt;!-- 1. Adam Curtis documentary: [Cant Get You Out of My Head E06](https://www.youtube.com/watch?v=pga0Oi1cZvo&amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;index=6 --&gt;

&lt;h1 id=&quot;other-media&quot;&gt;Other media&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Adam Curtis documentary: &lt;a href=&quot;https://www.youtube.com/watch?v=DPjSeZJmEVc&amp;amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;amp;index=3&quot;&gt;Cant Get You Out of My Head E03&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Dan Carlin’s Hardcore History - &lt;a href=&quot;https://www.dancarlin.com/product/hardcore-history-62-supernova-in-the-east-i/&quot;&gt;Supernova in the East I&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;</content><author><name></name></author><category term="weeknotes" /><summary type="html">Weeknotes</summary></entry><entry><title type="html">Weeknotes</title><link href="/2021/06/14/weeknotes_3.html" rel="alternate" type="text/html" title="Weeknotes" /><published>2021-06-14T00:00:00+02:00</published><updated>2021-06-14T00:00:00+02:00</updated><id>/2021/06/14/weeknotes_3</id><content type="html" xml:base="/2021/06/14/weeknotes_3.html">&lt;h1 id=&quot;weeknotes&quot;&gt;Weeknotes&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;14 June 2021&lt;/p&gt;

&lt;h1 id=&quot;work&quot;&gt;Work&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Using RCy3 to programmatically control Cytoscape for downloading STRINGdb in analysis.&lt;/li&gt;
  &lt;li&gt;Writing up paper on protein network analysis.&lt;/li&gt;
  &lt;li&gt;Writing paper on &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&amp;amp;VirusLineage_ss=Human%20orthopneumovirus,%20taxid:11250&quot;&gt;viral association genetics&lt;/a&gt;.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;personal&quot;&gt;Personal&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Spent time in &lt;a href=&quot;https://goo.gl/maps/TVz7B33HcDRy6FDF8&quot;&gt;Robella Val-de-Travers, Neuchâtel&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Rewrote most CSS on my website as learning for online classes.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;reading&quot;&gt;Reading&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;&lt;a href=&quot;https://en.wikipedia.org/wiki/The_Honourable_Schoolboy&quot;&gt;The Honourable Schoolboy&lt;/a&gt;, John le Carré.&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://www.medrxiv.org/content/10.1101/2021.05.04.21256612v1.full.pdf&quot;&gt;Bowden et al., 2021 &lt;/a&gt;, The Triangulation WIthin A STudy (TWIST) framework for causal inference within Pharmacogenetic research.&lt;/li&gt;
  &lt;li&gt;Reread &lt;a href=&quot;https://www.nature.com/articles/s41576-019-0177-4&quot;&gt;Povysil et al., 2019&lt;/a&gt;, Rare-variant collapsing analyses for complex traits: guidelines and applications.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;other-media&quot;&gt;Other media&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Adam Curtis documentary: &lt;a href=&quot;https://www.youtube.com/watch?v=xanSAr83w-k&amp;amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;amp;index=2&quot;&gt;Cant Get You Out of My Head E02&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Lex Fridman Podcast: &lt;a href=&quot;https://lexfridman.com/charles-hoskinson/&quot;&gt;#192 Charles Hoskinson: Cardano&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;</content><author><name></name></author><category term="weeknotes" /><summary type="html">Weeknotes</summary></entry><entry><title type="html">SARS-CoV-2 variants of concern</title><link href="/2021/06/07/variants_of_concern.html" rel="alternate" type="text/html" title="SARS-CoV-2 variants of concern" /><published>2021-06-07T00:00:00+02:00</published><updated>2021-06-07T00:00:00+02:00</updated><id>/2021/06/07/variants_of_concern</id><content type="html" xml:base="/2021/06/07/variants_of_concern.html">&lt;h1 id=&quot;sars-cov-2-variants-of-concern&quot;&gt;SARS-CoV-2 variants of concern&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;07 June 2021&lt;/p&gt;

&lt;h1 id=&quot;variants-of-concern-aligned-to-vaccine-coding-sequences&quot;&gt;Variants of concern aligned to vaccine coding sequences&lt;/h1&gt;

&lt;p&gt;This work has not been peer reviewed.&lt;/p&gt;

&lt;p&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern_to_vaccine.pdf&quot;&gt;Open PDF visualisation - variants_of_concern_to_vaccine.pdf&lt;/a&gt;&lt;/p&gt;

&lt;h2 id=&quot;aims-and-results&quot;&gt;Aims and results&lt;/h2&gt;
&lt;ul&gt;
  &lt;li&gt;To produce standardized alignments of vaccine sequences.&lt;/li&gt;
  &lt;li&gt;Determine which are at risk to emerging variants.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;From the data presented within:&lt;/p&gt;

&lt;ol&gt;
  &lt;li&gt;The translated amino acid sequences for all vaccines were derived.&lt;/li&gt;
  &lt;li&gt;These were aligned to the SARS-CoV-2 reference amino acid sequences of spike glycoprotein.&lt;/li&gt;
  &lt;li&gt;Known variants-of-concern were then annotated and visualised.&lt;/li&gt;
&lt;/ol&gt;

&lt;h2 id=&quot;overview&quot;&gt;Overview&lt;/h2&gt;
&lt;p&gt;Variants-of-concern for five SARS-CoV-2 strains 
(&lt;a href=&quot;https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcases-updates%2Fvariant-surveillance%2Fvariant-info.html&quot;&gt;CDC 4 Jun 2021&lt;/a&gt;)
are illustrated against the 
translated amino acid sequences of the vaccines;&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Moderna mRNA-1273&lt;/li&gt;
  &lt;li&gt;Pfizer/BioNTech BNT-162b2&lt;/li&gt;
  &lt;li&gt;Janssen/Johnson &amp;amp; Johnson Ad26.COV2-S&lt;/li&gt;
  &lt;li&gt;Novavax NVX-CoV2373&lt;/li&gt;
  &lt;li&gt;Curevac CVnCoV&lt;/li&gt;
  &lt;li&gt;Sputnik V&lt;/li&gt;
  &lt;li&gt;AstraZeneca AZD1222&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;and reference genome sequences;&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;QHD43416.1 [MN908947.3] and&lt;/li&gt;
  &lt;li&gt;YP_009724390.1 [NC_045512.2].&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;The variants-of-concern are shown here, illustrated on the protein structure;
&lt;a href=&quot;https://www.rcsb.org/structure/6ZOX&quot;&gt;6ZOX.pdb DOI: 10.2210/pdb6ZOX/pdb&lt;/a&gt;
&lt;em&gt;Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x2 disulphide-bond mutant, G413C, V987C, single Arg S1/S2 cleavage site),&lt;/em&gt;
provided by Xiong et al., 2020 &lt;a href=&quot;https://www.nature.com/articles/s41594-020-0478-5&quot;&gt;10.1038/s41594-020-0478-5&lt;/a&gt;.&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/pdb/renders/6zox_voc_20210604_front.jpg&quot;&gt;6zox_voc_20210604_front.jpg&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/pdb/renders/6zox_voc_20210604_side.jpg&quot;&gt;6zox_voc_20210604_side.jpg&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/pdb/renders/6zox_voc_20210604_top.jpg&quot;&gt;6zox_voc_20210604_top.jpg&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;img src=&quot;/images/posts/6zox_voc_20210604_stage.gif&quot; width=&quot;100%&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Two of the defining genetic features that are different between vaccines are seen here,&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;the S glycoprotein furin cleavage modification region (p.682-685)&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;img src=&quot;/images/posts/snapshot_furin_cleavage_region.png&quot; width=&quot;100%&quot; /&gt;&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;the S glycoprotein stabilization modification region (p.986-987)&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;img src=&quot;/images/posts/snapshot_stabilizing_region_PP.png&quot; width=&quot;100%&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Visual alignment is shown against translated coding sequence for spike glycoprotein,
illustrated here via&lt;/p&gt;

&lt;p&gt;&lt;a href=&quot;https://nextstrain.org/sars-cov-2&quot;&gt;nextstrain.org&lt;/a&gt;.
&lt;img src=&quot;/images/posts/nextstrain_spike.png&quot; width=&quot;100%&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Fasta sequences are included for:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Variants of Concern B.1.1.7&lt;/li&gt;
  &lt;li&gt;Variants of Concern B.1.351&lt;/li&gt;
  &lt;li&gt;Variants of Concern B.1.427&lt;/li&gt;
  &lt;li&gt;Variants of Concern B.1.429&lt;/li&gt;
  &lt;li&gt;Variants of Concern P.1&lt;/li&gt;
  &lt;li&gt;Ref QHD43416.1 [MN908947.3]&lt;/li&gt;
  &lt;li&gt;Ref YP_009724390.1 [NC_045512.2]&lt;/li&gt;
  &lt;li&gt;mRNA-1273 vaccine translated&lt;/li&gt;
  &lt;li&gt;BNT-162b2 vaccine translated&lt;/li&gt;
  &lt;li&gt;Ad26.COV2-S vaccine translated&lt;/li&gt;
  &lt;li&gt;NVX-CoV2373 vaccine translated&lt;/li&gt;
  &lt;li&gt;Sputnik V alleged unmodified YP_009724390.1&lt;/li&gt;
  &lt;li&gt;AZD1222 alleged unmodified YP_009724390.1&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;reference-genome-sequence&quot;&gt;Reference genome sequence&lt;/h2&gt;
&lt;p&gt;The two reference sequences that are used by vaccine developers are;&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Complete genome DNA and translated coding sequences:
    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/nuccore/NC_045512.2&quot;&gt;NC_045512.2&lt;/a&gt;,&lt;/li&gt;
      &lt;li&gt;Protein ID for spike glycoprotein &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/protein/YP_009724390.1&quot;&gt;YP_009724390.1&lt;/a&gt;.&lt;/li&gt;
      &lt;li&gt;Date: 18-JUL-2020&lt;/li&gt;
      &lt;li&gt;This the same translated protein sequence as that is referred to based on genomic coordinates &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/nuccore/NC_045512&quot;&gt;NC_045512.2:21563-25384 translated GU280_gp02&lt;/a&gt;&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Complete genome DNA and translated coding sequences:
    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/nuccore/mn908947.3&quot;&gt;MN908947.3&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;Protein ID for spike glycoprotein &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/protein/QHD43416.1&quot;&gt;QHD43416.1&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;Date: 18-MAR-2020&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;Both reference sequences are provided in files:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_reference_sequence/reference_sequence_NC_045512.2.21563-25384.md&quot;&gt;reference_sequence_NC_045512.2.21563-25384.md&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_reference_sequence/reference_sequence_MN908947.3.md&quot;&gt;reference_sequence_MN908947.3.md&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;vaccine-sequence-reproduction&quot;&gt;Vaccine sequence reproduction&lt;/h2&gt;
&lt;p&gt;The sequences for vaccines have been reproduced by careful reconstruction based on&lt;/p&gt;

&lt;ol&gt;
  &lt;li&gt;The authors’ reported reference sequence and&lt;/li&gt;
  &lt;li&gt;The description of the genetic modifications used during vaccine development.&lt;/li&gt;
&lt;/ol&gt;

&lt;p&gt;The primary sources are provided in each case, along with a detailed description of the genetic variants provided by authors.
Additionally, the correct &lt;a href=&quot;https://varnomen.hgvs.org/recommendations&quot;&gt;HGVS-recommended nomenclature&lt;/a&gt; has been used for more reliable reproduction than some of the primary sources.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;For visual simplicity, an X symbol was used to illustrate amino acid deletions&lt;/strong&gt;.
All other amino acid changes use their correct symbol.&lt;/p&gt;

&lt;p&gt;For vaccines BNT-162b2 and mRNA-1273, the assemblies have also been sourced from &lt;a href=&quot;https://github.com/NAalytics/Assemblies-of-putative-SARS-CoV2-spike-encoding-mRNA-sequences-for-vaccines-BNT-162b2-and-mRNA-1273&quot;&gt;NAalytics&lt;/a&gt;.
This data matches the vaccine sequences that have been reproduced here based on primary literature.
Briefly, 
their experimental sequence information from the initial 
Moderna (&lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32756549/&quot;&gt;Corbett Nature 2020 Oct&lt;/a&gt;)
and Pfizer/BioNTech (&lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33301246/&quot;&gt;Polack NEJM 2020 Dec&lt;/a&gt;)
COVID-19 vaccines, allowed them to produce a working assembly of the former 
and a confirmation of previously reported sequence information for the latter RNA.
Their data was sourced and formatted to select the coding sequences.
The nucleotide sequences were then translated into amino acid coding sequences
using &lt;a href=&quot;https://web.expasy.org/translate/&quot;&gt;https://web.expasy.org/translate/&lt;/a&gt;,
as shown in files:&lt;/p&gt;

&lt;p&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/sarscov2_vaccine_sequences_translated/sarscov2_vaccine_sequence_translated_mRNA-1273.md&quot;&gt;sarscov2_vaccine_sequence_translated_mRNA-1273.md&lt;/a&gt;
&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/sarscov2_vaccine_sequences_translated/sarscov2_vaccine_sequence_translated_BNT-162b2.md&quot;&gt;sarscov2_vaccine_sequence_translated_BNT-162b2.md&lt;/a&gt;&lt;/p&gt;

&lt;h2 id=&quot;covid-19-vaccine-sequences-summarised&quot;&gt;Covid-19 vaccine sequences summarised&lt;/h2&gt;
&lt;p&gt;The correct &lt;a href=&quot;https://varnomen.hgvs.org/recommendations/protein/variant/delins/&quot;&gt;HGVS standard notation is used&lt;/a&gt;.&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;mRNA-1273
    &lt;ul&gt;
      &lt;li&gt;Genetics: p.(Lys986_Val987delinsProPro)			- stabilizing x2 (PP)&lt;/li&gt;
      &lt;li&gt;Delivery: Lipid-nanoparticle&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;BNT162b2
    &lt;ul&gt;
      &lt;li&gt;Genetics: p.(Lys986_Val987delinsProPro)			- stabilizing x2 (PP)&lt;/li&gt;
      &lt;li&gt;Delivery: Lipid-nanoparticle&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Ad26.COV2-S
    &lt;ul&gt;
      &lt;li&gt;Genetics: p.[Arg682Ser;p.Arg685Gln]				- furin cleavage x2 (SRAG)&lt;/li&gt;
      &lt;li&gt;Genetics: p.(Lys986_Val987delinsProPro)			- stabilizing x2 (PP)&lt;/li&gt;
      &lt;li&gt;Delivery: Adenovirus vector (Ad26)&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;NVX-CoV2373
    &lt;ul&gt;
      &lt;li&gt;Genetics: p.[Arg682_Arg683delinsGlnGln;Arg685Gln]	- furin cleavage x3 (GGAG)&lt;/li&gt;
      &lt;li&gt;Genetics: p.(Lys986_Val987delinsProPro)				- stabilizing x2 (PP)&lt;/li&gt;
      &lt;li&gt;Delivery: Lipid-nanoparticle, baculovirus expression cultured in Sf9&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Sputnik V
    &lt;ul&gt;
      &lt;li&gt;Genetics: “unmodified” full-length S-protein&lt;/li&gt;
      &lt;li&gt;Genetics: No reference sequence found&lt;/li&gt;
      &lt;li&gt;Delivery: Adenovirus vectors (Ad26 dose 1) and (Ad5 dose 2)&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;Incomplete others:&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;CVnCoV
    &lt;ul&gt;
      &lt;li&gt;Genetics: modified S protein.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;AZD1222
    &lt;ul&gt;
      &lt;li&gt;Genetics: Unmodified S protein&lt;/li&gt;
      &lt;li&gt;Genetics: No reference sequence found&lt;/li&gt;
      &lt;li&gt;Adenovirus vector (ChAdOx1).&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;CoronaVac
    &lt;ul&gt;
      &lt;li&gt;a preparation of inactivated SARS-CoV-2 virions.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;covid-19-vaccine-details&quot;&gt;Covid-19 vaccine details&lt;/h2&gt;
&lt;ul&gt;
  &lt;li&gt;BioNTech/Pfizer: BNT162b2
    &lt;ul&gt;
      &lt;li&gt;Modified mRNA-in-lipid-nanoparticle vaccine&lt;/li&gt;
      &lt;li&gt;Expressing a modified S protein.&lt;/li&gt;
      &lt;li&gt;Stabiliazation by proline substitutions p.K986P, p.V987P.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Moderna: mRNA-1273
    &lt;ul&gt;
      &lt;li&gt;Modified mRNA-in-lipid-nanoparticle vaccine&lt;/li&gt;
      &lt;li&gt;Expressing a modified S protein.&lt;/li&gt;
      &lt;li&gt;Stabiliazation by proline substitutions p.K986P, p.V987P.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Janssen/Johnson &amp;amp; Johnson: Ad26.COV2-S aka JNJ-78436735
    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;https://www.biorxiv.org/content/10.1101/2020.07.30.227470v1&quot;&gt;Pre-prindt&lt;/a&gt;, &lt;a href=&quot;https://www.nature.com/articles/s41541-020-00243-x&quot;&gt;Published&lt;/a&gt;.&lt;/li&gt;
      &lt;li&gt;Adenovirus serotype 26 (Ad26) viral vector vaccine&lt;/li&gt;
      &lt;li&gt;Expressing a modified S protein.&lt;/li&gt;
      &lt;li&gt;S protein of SARS-CoV-2 corresponding to positions 21,536–25,384 in SARS-CoV-2 isolate Wuhan-Hu-1 (genome MN908947 (18-MAR-2020))&lt;a href=&quot;https://www.nature.com/articles/s41541-020-00243-x&quot;&gt;Published&lt;/a&gt;.&lt;/li&gt;
      &lt;li&gt;For Ad26.S.PP, the two stabilising variants p.(Lys986_Val987delinsProPro) are included as well as two mutations in the furin cleavage site that preserve the prefusion conformation and blocks shedding of S1.&lt;/li&gt;
      &lt;li&gt;The furin cleavage site was abolished by amino acid changes p.R682S and p.R685G.&lt;/li&gt;
      &lt;li&gt;Stabiliazation by proline substitutions p.K986P, p.V987P.&lt;/li&gt;
      &lt;li&gt;The correct &lt;a href=&quot;https://varnomen.hgvs.org/recommendations/protein/variant/delins/&quot;&gt;HGVS standard notation&lt;/a&gt; should be: p.[Arg682Ser;p.Arg685Gln] and p.(Lys986_Val987delinsProPro).&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Novavax: NVX-CoV2373
    &lt;ul&gt;
      &lt;li&gt;A protein subunit vaccine containing a doubly modified S protein, with adjuvant.&lt;/li&gt;
      &lt;li&gt;Part of a 27.2nm nanoparticle.&lt;/li&gt;
      &lt;li&gt;S protein of SARS-CoV-2 corresponding to GenBank MN908947 nucleotides 21563-25384 &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584426/&quot;&gt;as published&lt;/a&gt;.&lt;/li&gt;
      &lt;li&gt;Contains the modified S protein with the two Proline substitutions, K986P and V987P. Additionally, three amino acids are changed (682-RRAR-685 to 682-QQAQ-685) to protect the protein against proteases.&lt;/li&gt;
      &lt;li&gt;The authors failed to write the correct &lt;a href=&quot;https://varnomen.hgvs.org/recommendations/protein/variant/delins/&quot;&gt;HGVS standard notation&lt;/a&gt;: p.[Arg682_Arg683delinsGlnGln;Arg685Gln] and p.(Lys986_Val987delinsProPro),
a simple list would even be better: p.R682Q, p.R683Q, p.R685Q, p.K986P, and p.V987P.&lt;/li&gt;
      &lt;li&gt;Saponin-based Matrix-M adjuvent.&lt;/li&gt;
      &lt;li&gt;Protein expression by a baculovirus in an Sf9 insect infection culture.&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;https://www.biorxiv.org/content/10.1101/2020.06.29.178509v1.full.pdf&quot;&gt;https://www.biorxiv.org/content/10.1101/2020.06.29.178509v1.full.pdf&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;Delivery in lipid nanoparticle&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Gamaleya Research Institute of Epidemiology and Microbiology: Sputnik V
    &lt;ul&gt;
      &lt;li&gt;aka Гам-КОВИД-Вак (Gam-COVID-Vac).&lt;/li&gt;
      &lt;li&gt;Two differnt adenovirus viral vectors.&lt;/li&gt;
      &lt;li&gt;Uses two different adenovirus serotypes; &lt;a href=&quot;https://sputnikvaccine.com/about-vaccine/&quot;&gt;recombinant Ad26 (dose 1) and recombinant Ad5 (dose 2)&lt;/a&gt;.&lt;/li&gt;
      &lt;li&gt;Both carrying the gene for Spike glycoprotein (rAd26-S and rAd5-S).&lt;/li&gt;
      &lt;li&gt;Antigen insert is an “unmodified” full-length S-protein (no reference sequence).&lt;/li&gt;
      &lt;li&gt;Produced in HEK293 cell line.&lt;/li&gt;
      &lt;li&gt;No reference sequence found&lt;/li&gt;
      &lt;li&gt;The first major paper [Logunov et al Lancet. 2020] is this clinical trial of frozen and lyophilised vaccine. It mentions previous unpublished pre-clinical trials. &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471804/&quot;&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471804/&lt;/a&gt;&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Curevac: CVnCoV
    &lt;ul&gt;
      &lt;li&gt;Unmodified mRNA-in-lipid-nanoparticle vaccine&lt;/li&gt;
      &lt;li&gt;Expressing a modified S protein.&lt;/li&gt;
      &lt;li&gt;Based on genome from first isolate &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/nuccore/NC_045512.2&quot;&gt;NC_045512.2&lt;/a&gt;, Spike glycoprotein &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/protein/YP_009724390.1&quot;&gt;YP_009724390.1&lt;/a&gt;.&lt;/li&gt;
      &lt;li&gt;full-length S featuring K986P and V987P mutations.&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33863911/&quot;&gt;https://pubmed.ncbi.nlm.nih.gov/33863911/&lt;/a&gt;&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Oxford/AstraZeneca: AZD1222 (formerly ChAdOx1 nCoV-19)
    &lt;ul&gt;
      &lt;li&gt;A viral vector vaccine&lt;/li&gt;
      &lt;li&gt;Viral vector (ChAdOx1 - chimpanzee adenovirus Oxford 1, &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22808149/&quot;&gt;as published&lt;/a&gt;)&lt;/li&gt;
      &lt;li&gt;Expressing the unmodified S protein.&lt;/li&gt;
      &lt;li&gt;No reference sequence found&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;http://www.thelancet.com/retrieve/pii/S0140673620316044&quot;&gt;Folegatti et al, Lancet July 2020&lt;/a&gt;&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;vaccine-multiple-sequence-alignment&quot;&gt;Vaccine Multiple Sequence Alignment&lt;/h2&gt;
&lt;p&gt;The amino acid sequences of the coding region from each of the vaccine sequences 
and the reference sequence were used for multiple sequence alignment
via &lt;a href=&quot;https://www.ebi.ac.uk/Tools/msa/clustalo/&quot;&gt;https://www.ebi.ac.uk/Tools/msa/clustalo/&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;Variants-of-concern were then formatted to be used for annotation on the 
aligned sequences.&lt;/p&gt;

&lt;h2 id=&quot;variants-of-concern&quot;&gt;Variants of concern&lt;/h2&gt;
&lt;p&gt;SARS-CoV-2 Variant Classifications and Definitions were derived from
&lt;a href=&quot;https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcases-updates%2Fvariant-surveillance%2Fvariant-info.html&quot;&gt;https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcases-updates%2Fvariant-surveillance%2Fvariant-info.html&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;This dataset includes:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Variants of Interest (VOI)&lt;/li&gt;
  &lt;li&gt;Variants of Concern (VOC)&lt;/li&gt;
  &lt;li&gt;Variants of High Consequence (VOHC)&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;The reformatted tables are presented in files:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern.xlsx&quot;&gt;variants_of_concern.xlsx&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern.csv&quot;&gt;variants_of_concern.csv&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;There are currently no VOHC. 
VOC (but not VOI) were presented in the final visualisation.&lt;/p&gt;

&lt;h2 id=&quot;aligned-variants-of-concern-to-vaccine&quot;&gt;Aligned variants-of-concern to vaccine&lt;/h2&gt;

&lt;p&gt;The variants of concern were formatted such that one pseudo-fasta format entry 
contains the amino acid change for each strain. 
This data was then added to the multiple sequence alignment file to allow for
aligned annotations,
as shown in file:&lt;/p&gt;

&lt;p&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern_to_vaccine.fa&quot;&gt;variants_of_concern_to_vaccine.fa&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;The file contains the list the variants-of-concern for five Sars-CoV-2 strains,
2 reference sequence, and
6 vaccine sequences:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Variants of Concern B.1.1.7&lt;/li&gt;
  &lt;li&gt;Variants of Concern B.1.351&lt;/li&gt;
  &lt;li&gt;Variants of Concern B.1.427&lt;/li&gt;
  &lt;li&gt;Variants of Concern B.1.429&lt;/li&gt;
  &lt;li&gt;Variants of Concern P.1&lt;/li&gt;
  &lt;li&gt;Ref QHD43416.1 [MN908947.3]&lt;/li&gt;
  &lt;li&gt;Ref YP_009724390.1 [NC_045512.2]&lt;/li&gt;
  &lt;li&gt;mRNA-1273 vaccine translated&lt;/li&gt;
  &lt;li&gt;BNT-162b2 vaccine translated&lt;/li&gt;
  &lt;li&gt;Ad26.COV2-S vaccine translated&lt;/li&gt;
  &lt;li&gt;NVX-CoV2373 vaccine translated&lt;/li&gt;
  &lt;li&gt;Sputnik V alleged unmodified YP_009724390.1&lt;/li&gt;
  &lt;li&gt;AZD1222 alleged unmodified YP_009724390.1&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;img src=&quot;/images/posts/coronavirus-cutaway-600.png&quot; width=&quot;20%&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Different strains will contain benign variants.
Typically, full sequences are used for alignment. 
However, this can be visually distracting.
Instead, only the variants-of-concern are annotated for the strain sequences.&lt;/p&gt;

&lt;p&gt;The final illustration was made using &lt;a href=&quot;https://www.snapgene.com&quot;&gt;https://www.snapgene.com&lt;/a&gt; software.
The snapgene-software formatted output can be loaded with the file:&lt;/p&gt;

&lt;p&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern_to_vaccine.praln&quot;&gt;variants_of_concern_to_vaccine.praln&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;The final PDF version is shown in file:
&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern_to_vaccine.pdf&quot;&gt;Open PDF visualisation&lt;/a&gt;
&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern_to_vaccine.pdf&quot;&gt;variants_of_concern_to_vaccine.pdf&lt;/a&gt;&lt;/p&gt;

&lt;h2 id=&quot;main-files&quot;&gt;Main files&lt;/h2&gt;

&lt;p&gt;The main files that might interst you are listed here together.
Other files that are not listed contain intermediate data.&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2#readme&quot;&gt;README.md&lt;/a&gt;&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_reference_sequence/reference_sequence_NC_045512.2.21563-25384.md&quot;&gt;reference_sequence_NC_045512.2.21563-25384.md&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_reference_sequence/reference_sequence_MN908947.3.md&quot;&gt;reference_sequence_MN908947.3.md&lt;/a&gt;&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_vaccine_sequences_translated/sarscov2_vaccine_sequence_translated_mRNA-1273.md&quot;&gt;sarscov2_vaccine_sequence_translated_mRNA-1273.md&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_vaccine_sequences_translated/sarscov2_vaccine_sequence_translated_BNT-162b2.md&quot;&gt;sarscov2_vaccine_sequence_translated_BNT-162b2.md&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_vaccine_sequences_translated/sarscov2_vaccine_sequence_translated_NVX-CoV2373.md&quot;&gt;sarscov2_vaccine_sequence_translated_NVX-CoV2373.md&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_vaccine_sequences_translated/sarscov2_vaccine_sequence_translated_Ad26.COV2-S.md&quot;&gt;sarscov2_vaccine_sequence_translated_Ad26.COV2-S.md&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_vaccine_sequences_translated/sarscov2_vaccine_sequence_translated_AZD1222.md&quot;&gt;sarscov2_vaccine_sequence_translated_AZD1222.md&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_vaccine_sequences_translated/sarscov2_vaccine_sequence_translated_NVX-CoV2373.md&quot;&gt;sarscov2_vaccine_sequence_translated_NVX-CoV2373.md&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/sarscov2_vaccine_sequences_translated/sarscov2_vaccine_sequence_translated_Sputnik-V.md&quot;&gt;sarscov2_vaccine_sequence_translated_Sputnik-V.md&lt;/a&gt;&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern.xlsx&quot;&gt;variants_of_concern.xlsx&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern.csv&quot;&gt;variants_of_concern.csv&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern_to_vaccine.fa&quot;&gt;variants_of_concern_to_vaccine.fa&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern_to_vaccine.praln&quot;&gt;variants_of_concern_to_vaccine.praln&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/blob/master/variants_of_concern_to_vaccine.pdf&quot;&gt;variants_of_concern_to_vaccine.pdf&lt;/a&gt;&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;pdb/6zox.pdb&quot;&gt;Protein structure, original structure file&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/pdb/6zox_voc_20210604_stage.vmd&quot;&gt;Protein structure, VMD visualisation state 6zox_voc_20210604_stage.vmd&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/pdb/renders/6zox_voc_20210604_front.jpg&quot;&gt;Protein structure with variants of concern 6zox_voc_20210604_front.jpg&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/pdb/renders/6zox_voc_20210604_side.jpg&quot;&gt;Protein structure with variants of concern 6zox_voc_20210604_side.jpg&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://github.com/DylanLawless/variants_of_concern_to_vaccine_SARS-CoV2/tree/master/pdb/renders/6zox_voc_20210604_top.jpg&quot;&gt;Protein structure with variants of concern 6zox_voc_20210604_top.jpg&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;other-notes&quot;&gt;Other notes&lt;/h2&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;a href=&quot;notes.md&quot;&gt;notes.md&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;img src=&quot;/images/posts/ribosome-600.png&quot; width=&quot;100%&quot; /&gt;&lt;/p&gt;</content><author><name></name></author><category term="immunology" /><summary type="html">SARS-CoV-2 variants of concern</summary></entry><entry><title type="html">Weeknotes</title><link href="/2021/06/07/weeknotes_2.html" rel="alternate" type="text/html" title="Weeknotes" /><published>2021-06-07T00:00:00+02:00</published><updated>2021-06-07T00:00:00+02:00</updated><id>/2021/06/07/weeknotes_2</id><content type="html" xml:base="/2021/06/07/weeknotes_2.html">&lt;h1 id=&quot;weeknotes&quot;&gt;Weeknotes&lt;/h1&gt;

&lt;p class=&quot;meta&quot;&gt;7 June 2021&lt;/p&gt;

&lt;h1 id=&quot;work&quot;&gt;Work&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Writing methods on &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType_s=Nucleotide&amp;amp;VirusLineage_ss=Human%20orthopneumovirus,%20taxid:11250&quot;&gt;viral association genetics&lt;/a&gt;.&lt;/li&gt;
  &lt;li&gt;Genetic variance in viral clades.&lt;/li&gt;
  &lt;li&gt;Creating toy datasets for testing code.&lt;/li&gt;
  &lt;li&gt;Wrote code for power calcualtions with PPI network pathways and define the smallest testable sets (cohort sizes).&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;reading&quot;&gt;Reading&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;&lt;a href=&quot;https://en.wikipedia.org/wiki/The_Honourable_Schoolboy&quot;&gt;The Honourable Schoolboy&lt;/a&gt;, John le Carré.&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;https://www.amazon.com/Advanced-Level-Statistics-Francis/dp/0859508137&quot;&gt;Advanced level statistics&lt;/a&gt;, A. Francis. A good read on basic fundamentals but not a prefered over other modern textbooks with R code.&lt;/li&gt;
&lt;/ol&gt;

&lt;h1 id=&quot;other-media&quot;&gt;Other media&lt;/h1&gt;
&lt;ol&gt;
  &lt;li&gt;Oliver Nelson - &lt;a href=&quot;https://www.youtube.com/watch?v=k-zaI8lLrQA&quot;&gt;The Blues And The Abstract Truth 1961&lt;/a&gt;.&lt;/li&gt;
  &lt;li&gt;Podcast - BBC, In Our Time with Melvyn Bragg, &lt;a href=&quot;https://www.bbc.co.uk/programmes/b0435jyv&quot;&gt;Photosynthesis&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Adam Curtis documentary: &lt;a href=&quot;https://www.youtube.com/watch?v=hqX1J-1LyzA&amp;amp;list=PLt4ukDNowDWc0AvV8pImCrk4pK_tZXOyF&amp;amp;index=1&quot;&gt;Cant Get You Out of My Head E01&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;</content><author><name></name></author><category term="weeknotes" /><summary type="html">Weeknotes</summary></entry></feed>